Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Breast Cancer 2, Early Onset (BRCA2) Peptide

BRCA2 Reactivité: Humain, Singe, Rat Hôte: Synthetic BP
N° du produit ABIN2710836
  • Antigène Tous les produits BRCA2
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Origine
    Humain, Singe, Rat
    Source
    Synthetic
    Application
    Blocking Peptide (BP)
    Attributs du produit
    The peptide is used to block Anti-BRCA2 Antibody reactivity.
  • Indications d'application
    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Stock
    -20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year.
    Date de péremption
    12 months
  • Antigène
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Synonymes
    BRCC2 Peptide, BROVCA2 Peptide, FACD Peptide, FAD Peptide, FAD1 Peptide, FANCB Peptide, FANCD Peptide, FANCD1 Peptide, GLM3 Peptide, PNCA2 Peptide, 30169 Peptide, BcDNA:SD25109 Peptide, CG13583 Peptide, CG13584 Peptide, CG30169 Peptide, Dmel\\CG30169 Peptide, brca2 Peptide, dmbrca2 Peptide, fancd1 Peptide, BRCA2 Peptide, brcc2 Peptide, brovca2 Peptide, facd Peptide, fad Peptide, fad1 Peptide, fancb Peptide, AI256696 Peptide, AW045498 Peptide, Fancd1 Peptide, RAB163 Peptide, BRCA2, DNA repair associated Peptide, Breast cancer 2, early onset homolog Peptide, breast cancer 2, early onset Peptide, BRCA2 Peptide, Brca2 Peptide, brca2 Peptide, LOC584780 Peptide
    Sujet
    FACD, FANCD1, Breast cancer type 2 susceptibility protein, Fanconi anemia group D1 protein
    ID gène
    675
    UniProt
    P51587, O35923
Vous êtes ici:
Support technique